Dr. Lal PathLabs closes 50% higher on the BSE

23 Dec 2015 Evaluate

Dr. Lal PathLabs made a fabulous debut and snapped the session at Rs 824.15, a premium of 49.85% or higher by 274.15 points as against its issue price of Rs 550, on BSE.

The shares of the company debuted at Rs 717.00 and touched a high and low of Rs 842.40 and 715.50 respectively. A total of 49,69,000 shares were traded on the counter.

The issue price of Dr. Lal PathLabs was fixed at Rs 550 per share i.e. at the higher end of the price band of Rs 540-550 apiece. The offering was subscribed 33.41 times.

The objects of the Offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the Offer for Sale of up to 11,600,000 Equity Shares.

Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.

Dr. Lal Pathlabs Share Price

2863.20 -61.05 (-2.09%)
13-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6838.85
Max Healthcare Inst 1082.45
Narayana Hrudayalay 1271.05
Aster DM Healthcare 490.75
Global Health 1028.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.